cbdMD (YCBD) director Clark Crosnoe discloses indirect share sales

Rhea-AI Filing Summary

cbdMD, Inc. insider Clark R. Crosnoe, a director, reported multiple sales of the company’s common stock on 12/17/2025, all held indirectly through investment vehicles and trusts. These transactions are disclosed on a Form 4 filed for a single reporting person.

The filing shows a sale of 461,725 shares at $2.3136 per share through CRC Investment Fund LP, leaving 361,400 shares beneficially owned through that entity. It also reports a sale of 69,875 shares at $2.3444 per share through NM 2018 Trust, with 56,875 shares remaining, and a sale of 19,101 shares at $2.3444 per share through AMC Legacy Trust, with 17,875 shares remaining.

The reporting person states that beneficial ownership of these securities is disclaimed except to the extent of his pecuniary interest, so the reported indirect holdings reflect economic exposure rather than a claim to full ownership of all shares.

Insider Trade Summary

Net Seller: 550,701 shares ($1,276,842)

Net Sell 3 txns

Insider Crosnoe Clark R.

Role 10% Owner

Sold 550,701 shs ($1.28M)

Type	Security	Shares	Price	Value
Sale	Common Stock	461,725	$2.3136	$1.07M
Sale	Common Stock	69,875	$2.3444	$164K
Sale	Common Stock	19,101	$2.3444	$45K

Holdings After Transaction: Common Stock — 361,400 shares (Indirect, By CRC Investment Fund LP)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

X

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Crosnoe Clark R.

(Last) (First) (Middle)

4801 W. LOVERS LANE

(Street)

DALLAS TX 75209

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
cbdMD, Inc. [ YCBD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/17/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/17/2025		S		461,725	D	$2.3136	361,400(1)	I	By CRC Investment Fund LP
Common Stock	12/17/2025		S		69,875	D	$2.3444	56,875(1)	I	By NM 2018 Trust
Common Stock	12/17/2025		S		19,101	D	$2.3444	17,875(1)	I	By AMC Legacy Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

	/s/ Clark R. Crosnoe	12/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.